PRINTABLE VERSIONPRINTABLE VERSION EMAILEMAIL
Frost & Sullivan Awards CardioComm Solutions, Inc. the North American Enabling Technology Award for Cardiac Monitoring Technology.

CardioComm Solutions technology recognized as an enabler for quality remote access diagnostic interactions between consumers, patients, and physicians.

MOUNTAIN VIEW, Calif. - Tuesday, September 25, 2012 - Based on completion of their analysis of the cardiac rhythm monitoring technology industry, Frost & Sullivan recognizes CardioComm Solutions, Inc. ("CardioComm Solutions") with the 2012 North American Frost & Sullivan Award for Enabling Technology. CardioComm Solutions is especially recognized for leveraging its SMART Monitoring technology to launch a fully scalable and cost-effective electrocardiograph (ECG) and arrhythmia monitoring solution.

CardioComm Solutions has demonstrated industry leadership by introducing their ECG management and monitoring solutions, well-known in the medical establishment space, into the consumer market well ahead of its time. CardioComm Solutions is also the first company to offer over-the-counter (OTC) cardiac rhythm monitoring devices with the option of physician driven ECG interpretive services.

CardioComm Solutions focused on what it knew best, ECGs, and came up with the HeartCheck™ ECG Handheld Monitor, HeartCheck™ PEN, and SMART Monitoring service as an extension of their proprietary medical monitoring technologies. SMART Monitoring powers the HeartCheck™ devices using the company's proprietary GEMS™ and GlobalCardio™ software. The resulting cardiac monitoring solution is a globally expandable ECG and arrhythmia monitoring solution.

The prescriptive HeartCheck™ devices are portable, handheld, user-friendly devices which can take accurate readings anytime in just 30 seconds. The HeartCheck™ ECG monitor can store up to 200 ECG recordings. The OTC-cleared HeartCheck™ PEN can hold up to 20 heart rhythm recordings. Recorded data is rapidly transferred through the SMART Monitoring solution to a physician or medical call center through CardioComm Solutions' own GlobalCardio™ software. The HeartCheck™ PEN SMART Monitoring solution incorporates the company's consumer version of its proprietary GEMS™ software known as GEMS™ Home.

As further proof of its foresight, CardioComm Solutions is completing the rewriting of both its ECG management source code as well as ECG viewer programs to ensure compatibility with any new operating system that might come up in the next eight to ten years.

"CardioComm Solutions believes in a one-to-many, software-to-device relationship that allows its clients, whether they are hospitals, medical centers, or physicians' offices, the flexibility to buy the ECG monitoring hardware solution of their choice based on brand loyalty, cost, or workflow preferences," said Frost & Sullivan Research Analyst Darshana De.

The company is also focusing on developing product solutions for other biometric monitoring devices that can be used as OTC or prescriptive devices to measure basic and advanced biometric parameters, such as body weight, blood pressure, temperature, pulse oxymetry, and glucose.

CardioComm Solutions intends to persist with its device-agnostic approach to introduce software products solutions to the consumer market using its prudential prescription-based medical software. The company also plans to penetrate the sports and hard-labor market and provide effective monitoring for people who are active at the time of monitoring, such as during sports training.

Acknowledging patients' proactive knowledge garnering about a new device and the role played by governments and medical reimbursement groups in stoking technology acceptance, CardioComm Solutions is holding discussions with government and community medical authorities on enabling remote and mobile monitoring technology. It also provides physicians with direct exposure to its ECG technology offerings to improve awareness and adoption.

"CardioComm Solutions' strategy is to collaborate with companies, rather than compete with them, to build superior products and solutions," noted Darshana. "It is in discussion with several foreign companies that have affordable hardware technologies but lack the expertise to activate these technologies with the appropriate software solutions."

CardioComm Solutions is looking to sign more collaborative deals involving the expansion of GEMS™ and GlobalCardio™ licensing, greater use and sale of HeartCheck™ devices as point-of-care ECG monitors, and, finally, commercialization of its community and at-risk population arrhythmia screen tools.

These strategies have paid off for CardioComm Solutions, with end users from South America, Europe, Middle East, and Asia evincing interest in its solutions. Further, representatives from more than 50 countries have inquired about distribution rights for their products, indicating excellent prospects for market expansion.

"We were pleased to have been selected as a potential candidate for this award. Winning the 2012 award clearly speaks to our commitment of bringing disruptive technologies forward that will enable government sectors, consumers, patients and their doctors to close the gap between timely diagnosis and timely treatment of common and potentially life alerting cardiac disorders. Our company was recognized by both collaborators and competitors in Frost and Sullivan's review of the North American markets, highlighting that our progressive sales, marketing and R&D efforts are being taken note of ," said Etienne Grima, CEO of CardioComm Solutions. "We are appreciative and respectful of the work completed by Frost and Sullivan and will endeavor to show they were right in selecting our company".

Each year Frost & Sullivan presents this award to the company that has developed a technology that can benefit or revolutionize the industry. The award recipient has developed a system or enabling component of a system that removes a significant obstacle in the development of technology. The technology developed enables the creation of new products or modification of existing products to target new applications.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About CardioComm Solutions, Inc.

CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The Company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions is headquartered in Toronto, Canada, with offices in Victoria, British Columbia, Canada.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion
Join Us: Join our community
Subscribe: Newsletter on "the next big thing"
Register: Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com

BACK TO TOP BACK TO TOP

QUICK SEARCH

GO GO
ADVANCED SEARCH
Search our research by date, market, technology, region or keywords
GO GO
SHARE
ANALYST BRIEFINGS
Attend our complementary interactive analyst briefings
VIEW LIST  VIEW LIST
PRESS RELEASE MAILING LIST
To receive industry breaking news and analysis sign up for our mailing list. Include your full contact details and specify your industry of interest.
URGENT INQUIRIES
We recognize journalist deadlines and will strive to meet your needs as quickly as possible
CONTACT US   CONTACT US
Sitemap | Disclaimer | Privacy
© Frost & Sullivan
Conseq